▲ Peaking
Business
All eyes on data on Biogen’s tau therapy
Biogen's experimental anti-tau therapy shows promise in slowing cognitive decline for early Alzheimer's patients.
AAIC Biogen
1 news trends Newsylist has tracked involving AAIC Biogen — newest first.